Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Biotech
GSK pens $2.5B pact for ABL's blood-brain barrier-bypassing tech
GSK has continued to flesh out its neuroscience strategy with a $2.5 billion deal to use a South Korean biotech to bypass the blood-brain barrier.
James Waldron
Apr 7, 2025 7:00am
LifeMine lays off staff to focus on lead immunology asset
Mar 31, 2025 5:26pm
Sanofi snatches GSK R&D leader
Mar 31, 2025 1:26pm
GSK seeks link between shingles vax and lower dementia risk
Mar 25, 2025 5:00am
Curevo clinches $110M, nabs Moncef Slaoui to lead board
Mar 17, 2025 10:44am
Gilead's accounting chief hits the exit—Chutes & Ladders
Mar 14, 2025 8:30am
